Product Images Alendronate Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Alendronate Sodium NDC 33261-820 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical structure - alendronate 70 mg for teva 1
IMAGE LABEL - alendronate 70 mg for teva 10
This is a cautionary note indicating that dispensing this medicine without prescription is prohibited under federal law, and it should be kept out of reach of children. The medicine, Alendronate 70mg, is available in a pack containing 20 pills and the recommended storage temperature is between 15-30℃ (56.36℉). The medicine is made by Aidarex Pharmaceuticals LLC and also known by its generic name, Fosamax, and the active ingredient is Sodium. The recommended dosage and frequency are not provided in readable text. The manufacturing company is Teva Pharmaceuticals USA, and the location is Sellersville, PA 18960.*
figure 1 - alendronate 70 mg for teva 2
figure 2 - alendronate 70 mg for teva 3
figure 3 - alendronate 70 mg for teva 4
This appears to be a graph or chart displaying a study of Alendronate Sodium 10 mg over the course of 36 months, with time measured in months on the x-axis and numbers on the y-axis ranging from 0 to 10. However, without more information or context, it is difficult to say anything more specific about the study or its results.*
figure 3a - alendronate 70 mg for teva 5
This is not-available as the text is incomplete and doesn't provide enough information.*
figure 4 - alendronate 70 mg for teva 6
The text provides a table showing the mean percentage change and standard error of BMD (bone mineral density) for two-year study participants taking either alendronate sodium 5 mo/day or a placebo. The table displays the changes in BMD from baseline at different bone sites, including Femoral Trochanter, Neck, and Total Body.*
figure 4a - alendronate 70 mg for teva 7
figure 5 - alendronate 70 mg for teva 8
The text provides a comparison of the percent change in bone mineral density (BMD) at different sites of the body for individuals taking alendronate sodium 5 mg/day versus a placebo over a 2-year study period. The BMD change from the baseline is measured at three sites: femoral neck, trochanter, and total body. However, there are no specific percentages or measurements given to determine the extent of the change.*
figure 6 - alendronate 70 mg for teva 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.